🇺🇸 FDA
Pipeline program

ginkgolide

Yan 2018-015

Approved small_molecule completed

Quick answer

ginkgolide for Intravenous Alteplase Thrombolysis is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Intravenous Alteplase Thrombolysis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials